Cargando…
Plasma lncRNA LIPCAR Expression Levels Associated with Neurological Impairment and Stroke Subtypes in Patients with Acute Cerebral Infarction: A Prospective Observational Study with a Control Group
INTRODUCTION: This prospective observational study with a control group aimed to compare the plasma levels of long non-coding RNA (lncRNA) LIPCAR between patients with acute cerebral infarction (ACI) and healthy controls, and to assess the prognostic abilities of LIPCAR for adverse outcomes of patie...
Autores principales: | Liu, Zhong-zhong, Lin, Wen-juan, Feng, Yue, Huang, Cong-li, Yan, Yin-fang, Guo, Wei-yan, Zhang, Huan, Lei, Zhen, Lu, Qing-li, Liu, Pei, Lin, Xue-mei, Wu, Song-di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310665/ https://www.ncbi.nlm.nih.gov/pubmed/37195410 http://dx.doi.org/10.1007/s40120-023-00482-9 |
Ejemplares similares
-
Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population
por: Zhang, Zhen, et al.
Publicado: (2017) -
Circulating Long Noncoding RNA LIPCAR Acts as a Novel Biomarker in Patients with ST-Segment Elevation Myocardial Infarction
por: Li, Meng, et al.
Publicado: (2018) -
Elevated Levels of Circulating lncRNAs LIPCAR and MALAT1 Predict an Unfavorable Outcome in Acute Coronary Syndrome Patients
por: Barbalata, Teodora, et al.
Publicado: (2023) -
Study on Circulating lncRNA Expression Profile in Patients with Cerebral Infarction
por: Li, Man-tang, et al.
Publicado: (2022) -
Silencing of lncRNA XIST impairs angiogenesis and exacerbates cerebral vascular injury after ischemic stroke
por: Wang, Cong, et al.
Publicado: (2021)